+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breast Cancer"

From
From
From
From
From
From
Breast Cancer Screening Test Global Market Report 2025 - Product Thumbnail Image

Breast Cancer Screening Test Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Oncologists Global Market Opportunities and Strategies to 2032 - Product Thumbnail Image

Oncologists Global Market Opportunities and Strategies to 2032

  • Report
  • January 2024
  • 257 Pages
  • Global
From
From
From
Triple Negative Breast Cancer Global Market Report 2025 - Product Thumbnail Image

Triple Negative Breast Cancer Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Metastatic HR+/HER2- Breast Cancer Global Market Report 2025 - Product Thumbnail Image

Metastatic HR+/HER2- Breast Cancer Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
HER2-Negative Breast Cancer Global Market Report 2025 - Product Thumbnail Image

HER2-Negative Breast Cancer Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Breast Cancer Liquid Biopsy Global Market Report 2025 - Product Thumbnail Image

Breast Cancer Liquid Biopsy Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
Loading Indicator

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes. The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more